ASGCT turns the spotlight on immuno-oncology: where have we been & where are we going?

This August, the American Society of Gene & Cell Therapy (ASGCT) will run its inaugural Spotlight on Immuno-Oncology Conference. This two-day meeting, running in-person in Seattle and virtually, will feature a roster of I-O experts and highlight key topics for the field, including:

• Novel CAR designs;
• TCR-based approaches;
• Moving beyond B Cell malignancies;
• Genome/epigenome editing;
• Direct in vivo delivery;
• Looking beyond T cells.

To find out more, Roisin McGuigan, Editor, Immuno–Oncology Insights, spoke to 
Hans-Peter Kiem MD PhD, ASGCT’s Immediate Past President and Stephanus Family Endowed Chair for Cell and Gene Therapy, Fred Hutchinson Cancer Center, about the inspiration behind creating this new event.

Please enter your email to access content Read now